The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

Saved in:

Bibliographic Details
Main Authors:	Eiermann, Wolfgang (Author) , Rezai, Mahdi (Author) , Kümmel, Sherko (Author)
Other Authors:	Kühn, Thorsten (Other) , Warm, Mathias (Other) , Friedrichs, Kay (Other) , Schneeweiss, Andreas (Other) , Markmann, Susanne Christiane (Other) , Eggemann, Holm (Other) , Hilfrich, Jörn (Other) , Jackisch, Christian (Other) , Witzel, Isabell (Other) , Eidtmann, Holger (Other) , Bachinger, A. (Other) , Hell, Susanne (Other) , Blohmer, Jens-Uwe (Other)
Format:	Article (Journal)
Language:	English
Published:	2013
In:	Annals of oncology Year: 2013, Volume: 24, Issue: 3, Pages: 618-624
ISSN:	0923-7534
Online Access:
Author Notes:	W. Eiermann, M. Rezai, S. Kümmel, T. Kühn, M. Warm, K. Friedrichs, A. Schneeweiss, S. Markmann, H. Eggemann, J. Hilfrich, C. Jackisch, I. Witzel, H. Eidtmann, A. Bachinger, S. Hell & J. Blohmer

Description
ISSN:	0923-7534

Similar Items